Intrexon Corp. (XON) News Nov 17, 2014, 6:26 p.m.
Post# of 250674
Posted On: 11/18/2014 6:02:26 AM
Intrexon Corp. (XON) News Nov 17, 2014, 6:26 p.m.
MarketWatch News on XON
5 mid-cap stocks that insiders love 11:10 a.m. April 17, 2014 - Insider Monkey
Einhorn firm reports new stake in Intrexon 5:20 p.m. Nov. 14, 2013 - Bradley Hope
IPO scorecard: Rocket Fuel, FireEye, Benefitfocus 3:05 p.m. Sept. 24, 2013 - MarketWatch.com
Intrexon IPO prices at $16, top end of range 6:03 a.m. Aug. 8, 2013 - MarketWatch.com
Advertisement
Other News on XON
Intrexon's (XON) CEO Randal Kirk on Q3 2014 Results - Earnings Call Transcript 12:32 a.m. Nov. 14, 2014 - Seeking Alpha
10-Q: INTREXON CORP 4:50 p.m. Nov. 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Higher Expenses Hurt Intrexon (XON) Earnings in Q3? - Analyst Blog 10:50 a.m. Nov. 12, 2014 - Zacks.com
Stock To Watch: Intrexon (XON) In Perilous Reversal 10:01 a.m. Nov. 12, 2014 - TheStreet.com
Intrexon (XON) Looks Good: Stock Moves 11% Higher - Tale of the Tape 9:46 a.m. Nov. 12, 2014 - Zacks.com
Intrexon up on CNBC chatter 3:53 p.m. Nov. 11, 2014 - Seeking Alpha
10-Q: FIBROCELL SCIENCE, INC. 8:07 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Monopoly Hunt - Why Competition Is For Losers 9:22 p.m. Oct. 10, 2014 - Seeking Alpha
Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics 8:54 a.m. Oct. 10, 2014 - Seeking Alpha
Intrexon (XON) Is Today's Strong On High Volume Stock 10:06 a.m. Oct. 7, 2014 - TheStreet.com
Fibrocell and Intrexon to file IND for connective tissue disorder drug candidate 9:22 a.m. Sept. 24, 2014 - Seeking Alpha
3 Biotechnology Stocks to Sell Now 5:15 a.m. Sept. 17, 2014 - InvestorPlace.com
Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog 5:00 p.m. Sept. 16, 2014 - Zacks.com
4 Biotechnology Stocks to Sell Now 5:45 a.m. Sept. 10, 2014 - InvestorPlace.com
The Antibiotic Resistance Triple Threat 2:05 p.m. Sept. 4, 2014 - Seeking Alpha
Why Intrexon (XON) Could Be Positioned for a Slump - Tale of the Tape 8:36 a.m. Sept. 4, 2014 - Zacks.com
Greenlight Capital's Ideas That Are Most And Least Likely To Outperform 3:02 p.m. Aug. 29, 2014 - Seeking Alpha
Moving Average Crossover Alert: Intrexon (XON) - Tale of the Tape 9:52 a.m. Aug. 27, 2014 - Zacks.com
Oragenics: Interview With CEO Bonfiglio 1:50 a.m. Aug. 24, 2014 - Seeking Alpha
Tracking Dan Loeb's Third Point Portfolio - Q2 2014 Update 4:44 a.m. Aug. 22, 2014 - Seeking Alpha
Loading more headlines...
Press Releases on XON
Intrexon Announces Third Quarter 2014 Financial Results 4:01 p.m. Nov. 13, 2014 - PR Newswire - PRF
ROI Land Investments Ltd. Closes $6,000,000 Equity Investment 10:53 a.m. Nov. 12, 2014 - Thomson Reuters ONE
Critical Alerts For Rackspace Hosting, Intrexon, First Solar, News Corp and Microsoft Released By InvestorsObserver 9:31 a.m. Nov. 12, 2014 - PR Newswire - PRF
Soligenix Reports Third Quarter 2014 Financial Results, Highlighted with the Acquisition of SGX301, Synthetic Hypericin, for the Treatment of Cutaneous T-Cell Lymphoma 7:00 a.m. Nov. 10, 2014 - PR Newswire - PRF
Fibrocell Science Reports Third Quarter and Nine Month 2014 Financial and Operating Results 8:00 a.m. Nov. 7, 2014 - GlobeNewswire
Study Demonstrates Automated Laser-based Cell Manipulation with Intrexon's Proprietary LEAP® System 4:30 p.m. Nov. 6, 2014 - PR Newswire - PRF
Intrexon to Announce Third Quarter 2014 Results and Host Conference Call on November 13th 8:30 a.m. Nov. 6, 2014 - PR Newswire - PRF
Fibrocell Science to Report Third Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on November 7, 2014 4:06 p.m. Oct. 30, 2014 - GlobeNewswire
Critical Alerts For Infinera Corporation, Dana Holding, ServiceNow, Intrexon and CarMax Released By InvestorsObserver 9:31 a.m. Oct. 24, 2014 - PR Newswire - PRF
Fibrocell Science Honored With 2014 Marcum Innovator of the Year Award 8:01 a.m. Oct. 23, 2014 - GlobeNewswire
Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum Pharma, Sangamo BioSciences, and Cubist Pharma 9:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Histogenics and Intrexon Announce Formation of Exclusive Channel Collaboration for Cartilage Repair Therapies 8:30 a.m. Oct. 3, 2014 - PR Newswire - PRF
Fibrocell Science Announces Chief Financial Officer Transition 8:00 a.m. Oct. 3, 2014 - GlobeNewswire
BioPop Releases a Living, Bioluminescent Dinosaur: The Dino Pet 12:17 p.m. Oct. 2, 2014 - PR Newswire - PRF
Intrexon and Amneal Expand Relationship with Second Product Collaboration 8:30 a.m. Oct. 2, 2014 - PR Newswire - PRF
Fibrocell Science to Present at 2014 Stem Cell Meeting on the Mesa 8:00 a.m. Sept. 30, 2014 - BusinessWire - BZX
Fibrocell Science to Present at BioCentury NewsMakers of the Biotech Industry Conference 9:15 a.m. Sept. 25, 2014 - BusinessWire - BZX
Fibrocell Science and Intrexon Advance GM-HDF-COL7toward Clinical Developmentfor the Treatment ofRecessive Dystrophic Epidermolysis Bullosa 8:00 a.m. Sept. 24, 2014 - BusinessWire - BZX
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development 7:00 a.m. Sept. 23, 2014 - PR Newswire - PRF
Critical Alerts For Advanced Micro Devices, Intrexon, LinkedIn, Yum! Brands and Chevron Released By InvestorsObserver 9:31 a.m. Sept. 19, 2014 - PR Newswire - PRF
Loading more headlines...
MarketWatch News on XON
5 mid-cap stocks that insiders love 11:10 a.m. April 17, 2014 - Insider Monkey
Einhorn firm reports new stake in Intrexon 5:20 p.m. Nov. 14, 2013 - Bradley Hope
IPO scorecard: Rocket Fuel, FireEye, Benefitfocus 3:05 p.m. Sept. 24, 2013 - MarketWatch.com
Intrexon IPO prices at $16, top end of range 6:03 a.m. Aug. 8, 2013 - MarketWatch.com
Advertisement
Other News on XON
Intrexon's (XON) CEO Randal Kirk on Q3 2014 Results - Earnings Call Transcript 12:32 a.m. Nov. 14, 2014 - Seeking Alpha
10-Q: INTREXON CORP 4:50 p.m. Nov. 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Higher Expenses Hurt Intrexon (XON) Earnings in Q3? - Analyst Blog 10:50 a.m. Nov. 12, 2014 - Zacks.com
Stock To Watch: Intrexon (XON) In Perilous Reversal 10:01 a.m. Nov. 12, 2014 - TheStreet.com
Intrexon (XON) Looks Good: Stock Moves 11% Higher - Tale of the Tape 9:46 a.m. Nov. 12, 2014 - Zacks.com
Intrexon up on CNBC chatter 3:53 p.m. Nov. 11, 2014 - Seeking Alpha
10-Q: FIBROCELL SCIENCE, INC. 8:07 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Monopoly Hunt - Why Competition Is For Losers 9:22 p.m. Oct. 10, 2014 - Seeking Alpha
Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics 8:54 a.m. Oct. 10, 2014 - Seeking Alpha
Intrexon (XON) Is Today's Strong On High Volume Stock 10:06 a.m. Oct. 7, 2014 - TheStreet.com
Fibrocell and Intrexon to file IND for connective tissue disorder drug candidate 9:22 a.m. Sept. 24, 2014 - Seeking Alpha
3 Biotechnology Stocks to Sell Now 5:15 a.m. Sept. 17, 2014 - InvestorPlace.com
Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog 5:00 p.m. Sept. 16, 2014 - Zacks.com
4 Biotechnology Stocks to Sell Now 5:45 a.m. Sept. 10, 2014 - InvestorPlace.com
The Antibiotic Resistance Triple Threat 2:05 p.m. Sept. 4, 2014 - Seeking Alpha
Why Intrexon (XON) Could Be Positioned for a Slump - Tale of the Tape 8:36 a.m. Sept. 4, 2014 - Zacks.com
Greenlight Capital's Ideas That Are Most And Least Likely To Outperform 3:02 p.m. Aug. 29, 2014 - Seeking Alpha
Moving Average Crossover Alert: Intrexon (XON) - Tale of the Tape 9:52 a.m. Aug. 27, 2014 - Zacks.com
Oragenics: Interview With CEO Bonfiglio 1:50 a.m. Aug. 24, 2014 - Seeking Alpha
Tracking Dan Loeb's Third Point Portfolio - Q2 2014 Update 4:44 a.m. Aug. 22, 2014 - Seeking Alpha
Loading more headlines...
Press Releases on XON
Intrexon Announces Third Quarter 2014 Financial Results 4:01 p.m. Nov. 13, 2014 - PR Newswire - PRF
ROI Land Investments Ltd. Closes $6,000,000 Equity Investment 10:53 a.m. Nov. 12, 2014 - Thomson Reuters ONE
Critical Alerts For Rackspace Hosting, Intrexon, First Solar, News Corp and Microsoft Released By InvestorsObserver 9:31 a.m. Nov. 12, 2014 - PR Newswire - PRF
Soligenix Reports Third Quarter 2014 Financial Results, Highlighted with the Acquisition of SGX301, Synthetic Hypericin, for the Treatment of Cutaneous T-Cell Lymphoma 7:00 a.m. Nov. 10, 2014 - PR Newswire - PRF
Fibrocell Science Reports Third Quarter and Nine Month 2014 Financial and Operating Results 8:00 a.m. Nov. 7, 2014 - GlobeNewswire
Study Demonstrates Automated Laser-based Cell Manipulation with Intrexon's Proprietary LEAP® System 4:30 p.m. Nov. 6, 2014 - PR Newswire - PRF
Intrexon to Announce Third Quarter 2014 Results and Host Conference Call on November 13th 8:30 a.m. Nov. 6, 2014 - PR Newswire - PRF
Fibrocell Science to Report Third Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on November 7, 2014 4:06 p.m. Oct. 30, 2014 - GlobeNewswire
Critical Alerts For Infinera Corporation, Dana Holding, ServiceNow, Intrexon and CarMax Released By InvestorsObserver 9:31 a.m. Oct. 24, 2014 - PR Newswire - PRF
Fibrocell Science Honored With 2014 Marcum Innovator of the Year Award 8:01 a.m. Oct. 23, 2014 - GlobeNewswire
Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum Pharma, Sangamo BioSciences, and Cubist Pharma 9:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Histogenics and Intrexon Announce Formation of Exclusive Channel Collaboration for Cartilage Repair Therapies 8:30 a.m. Oct. 3, 2014 - PR Newswire - PRF
Fibrocell Science Announces Chief Financial Officer Transition 8:00 a.m. Oct. 3, 2014 - GlobeNewswire
BioPop Releases a Living, Bioluminescent Dinosaur: The Dino Pet 12:17 p.m. Oct. 2, 2014 - PR Newswire - PRF
Intrexon and Amneal Expand Relationship with Second Product Collaboration 8:30 a.m. Oct. 2, 2014 - PR Newswire - PRF
Fibrocell Science to Present at 2014 Stem Cell Meeting on the Mesa 8:00 a.m. Sept. 30, 2014 - BusinessWire - BZX
Fibrocell Science to Present at BioCentury NewsMakers of the Biotech Industry Conference 9:15 a.m. Sept. 25, 2014 - BusinessWire - BZX
Fibrocell Science and Intrexon Advance GM-HDF-COL7toward Clinical Developmentfor the Treatment ofRecessive Dystrophic Epidermolysis Bullosa 8:00 a.m. Sept. 24, 2014 - BusinessWire - BZX
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development 7:00 a.m. Sept. 23, 2014 - PR Newswire - PRF
Critical Alerts For Advanced Micro Devices, Intrexon, LinkedIn, Yum! Brands and Chevron Released By InvestorsObserver 9:31 a.m. Sept. 19, 2014 - PR Newswire - PRF
Loading more headlines...
(0)
(0)